October 28, 2026 · Journal of the American Society of Nephrology : JASN · DOI: 10.1681/ASN.0000001318

Proteinuria, eGFR Decline, and the Pathway to Kidney Failure in Alport Syndrome.

Listen to this summary

This review asks how proteinuria and eGFR decline relate to progression toward kidney failure in Alport syndrome, and which measures best serve as clinical trial endpoints. The authors propose that proteinuria reflects early disease processes, with a partly reversible podocyte foot-process effacement component and a less reversible component tied to podocyte loss and glomerulosclerosis, while eGFR decline reflects later cumulative nephron loss. They conclude that biopsy markers are currently most useful for confirming target engagement, and that an endpoint framework should account for genotype, sex, age, baseline measures, and nonlinear disease trajectories.

Daniel P Gale, Jeffrey H Miner, Michelle N Rheault, Alessia Fornoni, Rachel Lennon

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play